FDA Approved: PIRFENIDONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for pirfenidone from Sandoz Inc, enabling a generic version to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)